相关实验视频

Updated: Jun 27, 2025

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells

Published on: February 21, 2018

急性髓性白血病中的CEBPA突变:对风险分层和治疗的影响

Feng-Ming Tien^1,2, Hsin-An Hou^3,4

¹Division of Hematology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.

International journal of hematology

|April 26, 2024

概括

在CCAAT增强剂结合蛋白α (CEBPA) 的突变影响急性髓性白血病 (AML) 的预后. 本综述考察了CEBPA突变,它们的临床异质性以及精密医学的潜在治疗点.

科学领域:

血液学血液学血液学
分子生物学分子生物学
在瘤学瘤学.

背景情况:

在新出现的急性髓性白血病 (AML) 患者中,约10%发现了CCAAT增强剂结合蛋白α (CEBPA) 突变.
在CEBPA基本素拉链域 (CEBPA^bZIP-inf) 中的框架内突变在最近的AML分类中被认为是不同的实体 (WHO-2022,ICC).
尽管有了更好的分类,但超过30%的CEBPAAML患者经历了治疗失败,突出了未满足的临床需求.

研究的目的:

在AML中全面审查CEBPA双基因突变 (CEBPA^dm) 和CEBPA^bZIP-inf中的异质性.
讨论与CEBPA变化并发突变的预后意义.
在CEBPA突变的AML.中确定未来药物开发的新型机制性标.

主要方法:

文献综述侧重于AML中的CEBPA突变.
对CEBPA^dm和CEBPA^bZIP-inf的临床数据和预后影响的分析.
探索新兴的机械见解和治疗策略.

主要成果:

在AML中,CEBPA^bZIP-inf突变代表了一个独特的预后子组,与传统的CEBPA^dm不同.
同时突变显著影响了CEBPA变异患者的临床过程和结果.
在CEBPA^bZIP-inf中存在异质性,这有助于对密集治疗的反应变化.

结论:

了解CEBPA突变的异质性对于准确的AML预后至关重要.
针对受CEBPA变化影响的特定分子通路可能会改善治疗结果.
需要精准医学方法来优化对有CEBPA突变的AML患者的临床管理.

关键词:

急性骨髓性白血病 (AML) 是一种急性骨髓性白血病.在CEBPA中,CEBPA是CEBPA的成员.这是白血病的产生.预测预后预测预测

更多相关视频

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

Engineering Oncogenic Heterozygous Gain-of-Function Mutations in Human Hematopoietic Stem and Progenitor Cells

Engineering Oncogenic Heterozygous Gain-of-Function Mutations in Human Hematopoietic Stem and Progenitor Cells

Published on: March 10, 2023

相关概念视频

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

Abnormal Proliferation

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...

Differentiation of Common Myeloid Progenitor Cells

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...